Certified by Founder Lodge
Novartis
Switzerland - Basel, Baselstadt
INVESTOR
1 Disclosed Funding Rounds $223,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treat
Company | Date | Round | Raised |
---|---|---|---|
Cleerly | July, 25 ,2022 | Series C | $223,000,000 |
Flare Therapeutics | March, 23 ,2023 | Series B | $123,000,000 |
RxLightning Inc. | June, 07 ,2023 | Series A | $17,500,000 |
Fore Biotherapeutics | August, 25 ,2023 | Series D | $75,000,000 |
Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |